Gene synthesis is an alternative to classic cloning that offers a precise way to create a gene and more control over the final gene that is developed. There are about 50 companies worldwide that offer gene synthesis services. The main advantages to outsourcing a project to one of these companies is that when a gene is created using gene synthesis antibody expression levels are typically higher; there is an increased ability to express difficult proteins; no genetic mutations are present; and outsourcing is convenient and saves internal lab time. Another consideration to keep in mind is the sometimes proprietary status of gene sequences and the trust that biotechnologists place in gene synthesis companies is very critical to long term success.
Improving expression levels is often a goal when using gene synthesis. Codon optimization is a service that takes the codon usage portion of the gene and matches it to the codon preferences of the expression host. This typically results in significantly higher expression levels of the antibody. There are also many other factors that can be optimized to make a better cell line including making adjustments to improve mRNA stability and various cis-elements in transcription and translation. The improvement in expression levels from gene synthesis was documented in a publication by GeneArt (now Life Technologies), titled “Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression,” it was shown that 86% of optimized genes showed higher expression than the corresponding wildtype; 100% of optimized genes showed expression while 12% of wildtype genes did not; and protein expressed from optimized genes was soluble and showed full functional activity.
In addition to improving expression levels, gene synthesis allows changes to the antibody at the genetic level to improve the final product. One example of this is with humanizing antibodies. Antibodies generated from one species, for instance mice, can be seen as foreign by the human body and can cause side effects in some patients that are similar to a severe allergic response. In addition because they are seen as foreign the body acts quickly to remove them from the blood stream meaning frequent dosing and an overall weaker immune response to the antigen. An effort has been made to use genetic engineering to create an antibody that contains more human DNA. Using gene synthesis, the mouse antibody is sequenced then some of the mouse DNA code is replaced with human DNA code and the result is either a chimeric antibody (usually about 33% mouse and 67% human) or a humanized antibody (usually 5-10% mouse and 90-95% human). These more human antibodies mean that the final medicine will be more readily accepted in the human patient and that the drug will remain in circulation thereby improving the immune response and reducing dosing requirements. Likewise the lack of mutation at the genetic level also creates a more pure antibody.
While performance benefits are often the driving factor, many companies are also finding that gene synthesis is more cost-effective than classic cloning. To conduct classic cloning, companies need to purchase the required olgionucleotides, molecular biology reagents and factor in a skilled scientist to do the work. Classic cloning is time consuming and draws internal resources away from other projects, so some companies are finding that outsourcing is a good alternative. This has not always been the case and five years ago the cost of gene synthesis was over $3 to $4 per base pair, which made it cost prohibitive and cheaper to do in-house. However, with gene synthesis companies employing the best machinery, specialized employees who are experts and high throughput, they have been able to reduce the cost to below 50 cents a base pair. This kind of pricing makes it very affordable to outsource. Specific pricing is variable and depends on the sequence type, the size of the sequence, what customization is requested and how much of the work the company wants to do internally, but in most cases it remains cost-effective to outsource. Some gene synthesis companies will also produce and purify the antibody in small volumes for an additional fee.
Today, gene synthesis offers easy, fast, and affordable access to almost any gene sequence. An attractive alternative to time consuming cloning and mutagenesis steps, gene synthesis offers researchers maximum design flexibility and makes it possible to receive a 100% correct clone in around 5 business days. By utilizing this technology scientists also have every sequence available and thus allows them to utilize the redundancy of the genetic code to optimize protein coding genes and open reading frames of choice for maximum protein expression. For these reasons, gene optimization and synthesis services offer an appealing alternative to traditional cloning. Companies offering gene synthesis services include Life Technologies, DNA 2.0, GenScript, and IDTn (Intergrated DNA).
|
Share this article with your social network, just click below to share now!
|
|
|
1 comment :
Very useful tips.................Certified medical coders are playing very important role in medical coding process with efficiency and accuracy. To complete their coding process successfully with accurately they have to undergo training like anatomy, physiology, medical terminology etc.
Certified Medical Coders
Post a Comment